CNS
HLNE

Donohue Michael T.

Known title: Managing Director & ControllerCIK: 0001698304

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 10, 2026

Cohen & Steers (CNS) eyes Q3 2026 results amid REIT sector resilience. A recent article highlights that REITs are holding up despite rising interest rates, driven by solid fundamentals. Cohen & Steers, Inc. is scheduled to release its third‑quarter 2026 earnings on October 15, providing more detail on its performance. The broader REIT strength may be relevant for CNS as it operates within that market.

this person other insiders at CNS

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 9, 2026

Wells Fargo initiates coverage on Hamilton Lane with Overweight rating. Wells Fargo has started covering Hamilton Lane, assigning an Overweight rating and a price target of $103. This new analyst view comes as the company prepares to report second-quarter results in November. Additionally, attention is turning to the planned 2027 retirement of a key executive, which may influence long-term expectations for the firm.

this person other insiders at HLNE

Transaction History

CNS▲ Buy$0
CNS▲ Buy$0
CNS▼ Sell$148K
CNS▲ Buy$0
CNS▲ Buy$0
CNS▲ Buy$0
HLNE▼ Sell$0
HLNE▲ Buy$5K
HLNE▼ Sell$29K
HLNE▲ Buy$0
HLNE▲ Buy$2K
HLNE▲ Buy$5K
HLNE▲ Buy$5K
HLNE▲ Buy$5K
HLNE▼ Sell$33K
HLNE▲ Buy$0
HLNE▲ Buy$5K
HLNE▲ Buy$5K
HLNE▲ Buy$5K
HLNE▲ Buy$5K

We use analytics to understand how market-wall is used. No personal data is sold.